• Return to Headlines

Shares of Retrophin Inc Fall to a New 52-Week Low

By James Quinn

Shares of Retrophin Inc (NASDAQ:RTRX) traded today at $11.45, breaking its 52-week low. This new low was reached on above average trading volume as 5.5 million shares traded hands, while the average 30-day volume is approximately 440,000 shares.

Retrophin Inc share prices have moved between a 52-week high of $33.00 and the current low of $11.45 and are currently at $12.45 per share. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.5% while the 200-day MA has slid 0.6%.

Retrophin, Inc. is a biotechnology company focused on discovering and developing treatments for rare and life-threatening diseases. The Company is currently developing treatments for Focal Segmental Glomerulosclerosis (FSGS), Pantothenate Kinase-Associated Neurodegeneration (PKAN), Duchenne Muscular Dystrophy, and other catastrophic diseases.

There is potential upside of 210.6% for shares of Retrophin Inc based on a current price of $12.45 and an average consensus analyst price target of $38.67. The stock should find initial resistance at its 50-day moving average (MA) of $19.72 and further resistance at its 200-day MA of $21.34.

SmarTrend recommended that its subscribers protect gains by selling shares of Retrophin Inc on August 2nd, 2019 by issuing a Downtrend alert when the shares were trading at $19.35. Since that call, shares of Retrophin Inc have fallen 10.1%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: 52 week high/lows retrophin inc

Ticker(s): RTRX